27.09.2011 • News

Celesio Sells Its Joint Venture Stake To Medco Health Solutions

Pharmaceutical and healthcare service provider Celesio and Medco Health Solutions Tuesday said they have mutually agreed to terminate their collaboration on offering services for chronically ill patients effective September 30.

Celesio sells its 50% share in the Medco Celesio joint venture to Medco Health Solutions. The two companies agreed to maintain confidentiality regarding the purchase price and other terms of the agreement.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.